iShares, the market’s largest purveyor of ETFs, filed paperwork with regulators to market a corporate bond fund that looks to build upon the success of the $25 billion iShares iBoxx $ Investment
The short interest in biotech and emerging pharmaceutical companies was mixed in the first two weeks of October. Shares sold short in Alexion Pharmaceuticals (NASDAQ: ALXN ), Amgen (NASDAQ:
There has been no shortage of chatter pertaining to dividend ETFs this year and with inflows to these funds soaring , it is evident investors like the idea of getting paid without having to